Satellos Bioscience Inc.
MSLE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001421642
No open-market purchases or sales by Satellos Bioscience Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $59.6M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Satellos Bioscience Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- −5 vs. Q1 2026
- Shares held
- 7.68M
- −300.3K (−3.8%) vs. Q1 2026
- Total value
- $59.6M
- +$13.7M (+29.9%) vs. Q1 2026
- New holders
- 2
- 6 more added
- Sold out
- 7
- 7 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MSLE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 26 | $59.6M |
| Q1 2026 | 31 | $45.9M |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Satellos Bioscience Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Franklin Resources Inc | 938,666 | $7.23M | 0.00% | 00.0% | Unchanged |
| Siren, L.L.C. | 892,074 | $6.94M | 0.14% | 00.0% | Unchanged |
| Vivo Capital, LLC | 813,666 | $6.33M | 0.58% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 682,700 | $5.31M | 0.01% | −8,078−1.2% | Reduced |
| Sphera Funds Management Ltd. | 652,590 | $5.07M | 0.73% | +163,383+33.4% | Added |
| Woodline Partners LP | 500,432 | $3.89M | 0.01% | 00.0% | Unchanged |
| Stonepine Capital Management, LLC | 491,624 | $3.72M | 2.83% | +391,624+391.6% | Added |
| Suvretta Capital Management, LLC | 475,000 | $3.69M | 0.08% | 00.0% | Unchanged |
| Avidity Partners Management LP | 387,769 | $3.01M | 0.48% | −387,769−50.0% | Reduced |
| Saturn V Capital Management LLC | 350,000 | $2.72M | 0.39% | 00.0% | Unchanged |
| Soleus Capital Management, L.P. | 314,359 | $2.44M | 0.08% | −100,000−24.1% | Reduced |
| 683 Capital Management, LLC | 230,833 | $1.79M | 0.17% | 00.0% | Unchanged |
| ADAR1 Capital Management, LLC | 222,555 | $1.73M | 0.08% | 00.0% | Unchanged |
| AWM Investment Company, Inc. | 180,000 | $1.40M | 0.12% | +180,000 | New |
| Millennium Management LLC | 152,768 | $1.19M | 0.00% | −145,665−48.8% | Reduced |
| Adage Capital Partners GP, L.L.C. | 150,000 | $1.17M | 0.00% | −230,354−60.6% | Reduced |
| Empery Asset Management, LP | 107,100 | $832.7K | 0.96% | −123,000−53.5% | Reduced |
| Citadel Advisors LLC | 67,738 | $526.7K | 0.00% | +25,246+59.4% | Added |
| Morgan Stanley | 25,732 | $200.1K | 0.00% | +4,549+21.5% | Added |
| China Universal Asset Management Co., Ltd. | 20,000 | $155.5K | 0.01% | +13,600+212.5% | Added |
| Royal Bank of Canada | 15,863 | $124.0K | 0.00% | −382−2.4% | Reduced |
| Geode Capital Management, LLC | 11,907 | $92.6K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 781 | $6.07K | 0.00% | +753+2,689.3% | Added |
| JPMorgan Chase & Co | 315 | $2.48K | 0.00% | +315 | New |
| Federation des caisses Desjardins du Quebec | 19 | $143 | 0.00% | 00.0% | Unchanged |
| Caitong International Asset Management Co., Ltd | 1 | $8 | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 0 | $0 | 0.00% | −30,461−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −19,608−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −12,000−100.0% | Sold out |
| Propel Bio Management, LLC | 0 | $0 | 0.00% | −10,145−100.0% | Sold out |
| Axq Capital, LP | 0 | $0 | 0.00% | −10,096−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −2,115−100.0% | Sold out |
| MAI Capital Management | 0 | $0 | 0.00% | −140−100.0% | Sold out |